EP08.01-095 Efficacy and Safety of Combining Endostar with Camrelizumab Plus Chemotherapy in Advanced NSCLC Patients: A Multi-Center Retrospective Study

L. Wu, X. X. Pu,L. B. Chen, Z. Q. Wang, Y. L. Liu,K. Li,Y. Kong,F. Xu, J. Li,L. Xu,Y. Xu, C. Y. Tang, L. M. Xiao,P. Liu

Journal of thoracic oncology（2022）

Cited 0|Views13

Key words

Endostar,Chemotherapy,Advanced NSCLC

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined